The purpose of this trial is to evaluate the safety and tolerability of INS115644 Ophthalmic Solution in subjects with bilateral ocular hypertension or early primary open angle glaucoma and to investigate the intraocular pressure lowering effects of INS115644 Ophthalmic Solution.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
56
One drop of Concentration #1 in one eye and one drop of placebo in contralateral eye every 12 hours for three days
One drop of placebo in each eye every 12 hours for three days
One drop of Concentration #2 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days
Safety and tolerability
Time frame: 28 days
Changes in intraocular pressure
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
One drop of Concentration #3 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days
One drop of Concentration #4 in one eye and one drop of placebo in the contralateral eye every twelve hours for three days